Diabetes, Newly Diagnosed and Monitoring Panel

Diabetes, Newly Diagnosed and Monitoring Panel

Test Code

91712
82947, 83036, 80061, 80076, 82570, 82043, 82565
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
91712
82947, 83036, 80061, 80076, 82570, 82043, 82565
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection may be available in your area for purchase through Quest Mobile.

Clinical Significance

Diabetes, Newly Diagnosed and Monitoring Panel - To assist with control of blood glucose levels, the American Diabetes Association (ADA) has recommended glycated hemoglobin testing (HbA1c) twice a year for patients with stable glycemia, and quarterly for patients with poor glucose control. Interpretative ranges are based on ADA guidelines.

Test Resources

Test FAQ

CKD-EPI Creatinine Equation (2021) for Creatinine-based eGFR

Test Guide

Laboratory Testing for Chronic Kidney Disease Diagnosis and Management

Test Guide

Laboratory Testing for Diabetes Diagnosis and Management

Test Summary

Creatinine-Based Estimated Glomerular Filtration Rate (eGFR)

Test Details

Includes

  • Glucose
  • Hemoglobin A1c
  • Lipid Panel: Total Cholesterol, HDL Cholesterol, Triglycerides, LDL-Cholesterol (calculated), Cholesterol/HDL Ratio (calculated), Non-HDL Cholesterol (calculated)
  • Hepatic Function Panel: Total Protein, Albumin, Globulin (calculated), Albumin/Globulin Ratio (calculated), Total Bilirubin, Direct Bilirubin, Indirect Bilirubin (calculated), Alkaline Phosphatase, AST, ALT
  • Microalbumin, Random Urine with Creatinine
  • Creatinine, Serum
  •  
  • If the Triglyceride result is >400 mg/dL, then Direct LDL will be performed at an additional charge (CPT code(s): 83721).

Patient Preparation

Patient should fast 9-12 hours prior to collection.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been. . . determined to interfere with assays for. . . cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.

Methodology

See individual tests

Reference Range(s)

See individual tests

LOINC® Codes, Performing Laboratory

Service Area must be determined
Glucose
Hemoglobin A1c
Lipid Panel: Total Cholesterol, HDL Cholesterol, Triglycerides, LDL-Cholesterol (calculated), Cholesterol/HDL Ratio (calculated), Non-HDL Cholesterol (calculated)
Hepatic Function Panel: Total Protein, Albumin, Globulin (calculated), Albumin/Globulin Ratio (calculated), Total Bilirubin, Direct Bilirubin, Indirect Bilirubin (calculated), Alkaline Phosphatase, AST, ALT
Microalbumin, Random Urine with Creatinine
Creatinine, Serum

If the Triglyceride result is >400 mg/dL, then Direct LDL will be performed at an additional charge (CPT code(s): 83721).
Patient should fast 9-12 hours prior to collection.
The assay manufacturer Beckman Coulter advises: "N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations (for the treatment of acetaminophen overdose), has been. . . determined to interfere with assays for. . . cholesterol, uric acid" where "NAC interference may lead to falsely low results." According to Beckman Coulter, the NAC interference should be insignificant by 12 hours after completion of the initial loading dose of an IV infusion treatment regimen consisting of an initial loading dose of 150 mg/kg administered over 1 hour, a second dose of 50 mg/kg administered over 4 hrs and a third dose of 100 mg/kg administered over 16 hrs.

Methodology

See individual tests

Reference Range(s)

See individual tests
Service Area must be determined

Preferred Specimen(s)

1 mL serum collected in a serum separator tube (SST) and
1 mL whole blood collected in an EDTA (lavender-top) tube and
10 mL random urine - no preservative

Minimum Volume

1 mL serum • 0.5 mL whole blood • 2 mL random urine

Transport Temperature

Serum: Refrigerated (cold packs)
Whole blood and urine: Room temperature

Specimen Stability

  • Serum
  • Room temperature: 24 hours
  • Refrigerated: 72 hours
  • Frozen: Unacceptable
  •  
  • Whole blood
  • Room temperature: 7 days
  • Refrigerated: 7 days
  • Frozen: 6 months
  •  
  • Random urine
  • Room temperature: 7 days
  • Refrigerated: 7 days
  • Frozen: 28 days

Reject Criteria

Serum: Gross hemolysis • Received frozen • Anticoagulants other than heparin • Moderate icterus • Unspun serum separator tube (SST) or non-plasma separator green-top tube
Whole blood: Sodium fluoride/oxalate (gray-top) tube
Random urine: Acid preserved urine

Setup Schedule

Service Area must be determined
1 mL serum collected in a serum separator tube (SST) and
1 mL whole blood collected in an EDTA (lavender-top) tube and
10 mL random urine - no preservative
1 mL serum • 0.5 mL whole blood • 2 mL random urine
Serum: Refrigerated (cold packs)
Whole blood and urine: Room temperature
Serum
Room temperature: 24 hours
Refrigerated: 72 hours
Frozen: Unacceptable

Whole blood
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 6 months

Random urine
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 28 days
Serum: Gross hemolysis • Received frozen • Anticoagulants other than heparin • Moderate icterus • Unspun serum separator tube (SST) or non-plasma separator green-top tube
Whole blood: Sodium fluoride/oxalate (gray-top) tube
Random urine: Acid preserved urine
Service Area must be determined
Not offered in Quest Diagnostics Nichols Institute (IFD) – San Juan Capistrano. Please provide SERVICE AREA INFORMATION to find available tests you can order.
In-home collection may be available in your area for purchase through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.

Customize the test information for your Service Area
We'd love your feedback! Take a brief survey.